The global market for Actinic (Solar) Keratosis Treatment was valued at US$ 3680 million in the year 2024 and is projected to reach a revised size of US$ 5503 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Actinic (Solar) Keratosis Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Actinic (Solar) Keratosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Actinic (Solar) Keratosis Treatment.

The Actinic (Solar) Keratosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Actinic (Solar) Keratosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Actinic (Solar) Keratosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Actinic (Solar) Keratosis Treatment Market Report

Report Metric	Details
Report Name	Actinic (Solar) Keratosis Treatment Market
Accounted market size in year	US$ 3680 million
Forecasted market size in 2031	US$ 5503 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	854-A ACT-01 AD-17137 Celecoxib DFD-08 GDC-695 Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	3M Drug Delivery Systems, Athenex Inc, CritiTech Inc, Foamix Pharmaceuticals Ltd, G&E Herbal Biotechnology Co Ltd, Galderma SA, Laboratories Ojer Pharma SL, LEO Pharma A/S, Novartis AG, Oncology Research International Ltd, Promius Pharma LLC, Valeant Pharmaceuticals International Inc, Vectura Group Plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Actinic (Solar) Keratosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Actinic (Solar) Keratosis Treatment Market growing?

Ans: The Actinic (Solar) Keratosis Treatment Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Actinic (Solar) Keratosis Treatment Market size in 2031?

Ans: The Actinic (Solar) Keratosis Treatment Market size in 2031 will be US$ 5503 million.

Who are the main players in the Actinic (Solar) Keratosis Treatment Market report?

Ans: The main players in the Actinic (Solar) Keratosis Treatment Market are 3M Drug Delivery Systems, Athenex Inc, CritiTech Inc, Foamix Pharmaceuticals Ltd, G&E Herbal Biotechnology Co Ltd, Galderma SA, Laboratories Ojer Pharma SL, LEO Pharma A/S, Novartis AG, Oncology Research International Ltd, Promius Pharma LLC, Valeant Pharmaceuticals International Inc, Vectura Group Plc

What are the Application segmentation covered in the Actinic (Solar) Keratosis Treatment Market report?

Ans: The Applications covered in the Actinic (Solar) Keratosis Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Actinic (Solar) Keratosis Treatment Market report?

Ans: The Types covered in the Actinic (Solar) Keratosis Treatment Market report are 854-A, ACT-01, AD-17137, Celecoxib, DFD-08, GDC-695, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 854-A

1.2.3 ACT-01

1.2.4 AD-17137

1.2.5 Celecoxib

1.2.6 DFD-08

1.2.7 GDC-695

1.2.8 Others

1.3 Market by Application

1.3.1 Global Actinic (Solar) Keratosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Actinic (Solar) Keratosis Treatment Market Perspective (2020-2031)

2.2 Global Actinic (Solar) Keratosis Treatment Growth Trends by Region

2.2.1 Global Actinic (Solar) Keratosis Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Actinic (Solar) Keratosis Treatment Historic Market Size by Region (2020-2025)

2.2.3 Actinic (Solar) Keratosis Treatment Forecasted Market Size by Region (2026-2031)

2.3 Actinic (Solar) Keratosis Treatment Market Dynamics

2.3.1 Actinic (Solar) Keratosis Treatment Industry Trends

2.3.2 Actinic (Solar) Keratosis Treatment Market Drivers

2.3.3 Actinic (Solar) Keratosis Treatment Market Challenges

2.3.4 Actinic (Solar) Keratosis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Actinic (Solar) Keratosis Treatment Players by Revenue

3.1.1 Global Top Actinic (Solar) Keratosis Treatment Players by Revenue (2020-2025)

3.1.2 Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Actinic (Solar) Keratosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Actinic (Solar) Keratosis Treatment Revenue

3.4 Global Actinic (Solar) Keratosis Treatment Market Concentration Ratio

3.4.1 Global Actinic (Solar) Keratosis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Actinic (Solar) Keratosis Treatment Revenue in 2024

3.5 Global Key Players of Actinic (Solar) Keratosis Treatment Head office and Area Served

3.6 Global Key Players of Actinic (Solar) Keratosis Treatment, Product and Application

3.7 Global Key Players of Actinic (Solar) Keratosis Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Actinic (Solar) Keratosis Treatment Breakdown Data by Type

4.1 Global Actinic (Solar) Keratosis Treatment Historic Market Size by Type (2020-2025)

4.2 Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Type (2026-2031)

5 Actinic (Solar) Keratosis Treatment Breakdown Data by Application

5.1 Global Actinic (Solar) Keratosis Treatment Historic Market Size by Application (2020-2025)

5.2 Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Actinic (Solar) Keratosis Treatment Market Size (2020-2031)

6.2 North America Actinic (Solar) Keratosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025)

6.4 North America Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Actinic (Solar) Keratosis Treatment Market Size (2020-2031)

7.2 Europe Actinic (Solar) Keratosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025)

7.4 Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size (2020-2031)

8.2 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Actinic (Solar) Keratosis Treatment Market Size (2020-2031)

9.2 Latin America Actinic (Solar) Keratosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025)

9.4 Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size (2020-2031)

10.2 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 3M Drug Delivery Systems

11.1.1 3M Drug Delivery Systems Company Details

11.1.2 3M Drug Delivery Systems Business Overview

11.1.3 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Introduction

11.1.4 3M Drug Delivery Systems Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.1.5 3M Drug Delivery Systems Recent Development

11.2 Athenex Inc

11.2.1 Athenex Inc Company Details

11.2.2 Athenex Inc Business Overview

11.2.3 Athenex Inc Actinic (Solar) Keratosis Treatment Introduction

11.2.4 Athenex Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.2.5 Athenex Inc Recent Development

11.3 CritiTech Inc

11.3.1 CritiTech Inc Company Details

11.3.2 CritiTech Inc Business Overview

11.3.3 CritiTech Inc Actinic (Solar) Keratosis Treatment Introduction

11.3.4 CritiTech Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.3.5 CritiTech Inc Recent Development

11.4 Foamix Pharmaceuticals Ltd

11.4.1 Foamix Pharmaceuticals Ltd Company Details

11.4.2 Foamix Pharmaceuticals Ltd Business Overview

11.4.3 Foamix Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Introduction

11.4.4 Foamix Pharmaceuticals Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.4.5 Foamix Pharmaceuticals Ltd Recent Development

11.5 G&E Herbal Biotechnology Co Ltd

11.5.1 G&E Herbal Biotechnology Co Ltd Company Details

11.5.2 G&E Herbal Biotechnology Co Ltd Business Overview

11.5.3 G&E Herbal Biotechnology Co Ltd Actinic (Solar) Keratosis Treatment Introduction

11.5.4 G&E Herbal Biotechnology Co Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.5.5 G&E Herbal Biotechnology Co Ltd Recent Development

11.6 Galderma SA

11.6.1 Galderma SA Company Details

11.6.2 Galderma SA Business Overview

11.6.3 Galderma SA Actinic (Solar) Keratosis Treatment Introduction

11.6.4 Galderma SA Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.6.5 Galderma SA Recent Development

11.7 Laboratories Ojer Pharma SL

11.7.1 Laboratories Ojer Pharma SL Company Details

11.7.2 Laboratories Ojer Pharma SL Business Overview

11.7.3 Laboratories Ojer Pharma SL Actinic (Solar) Keratosis Treatment Introduction

11.7.4 Laboratories Ojer Pharma SL Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.7.5 Laboratories Ojer Pharma SL Recent Development

11.8 LEO Pharma A/S

11.8.1 LEO Pharma A/S Company Details

11.8.2 LEO Pharma A/S Business Overview

11.8.3 LEO Pharma A/S Actinic (Solar) Keratosis Treatment Introduction

11.8.4 LEO Pharma A/S Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.8.5 LEO Pharma A/S Recent Development

11.9 Novartis AG

11.9.1 Novartis AG Company Details

11.9.2 Novartis AG Business Overview

11.9.3 Novartis AG Actinic (Solar) Keratosis Treatment Introduction

11.9.4 Novartis AG Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.9.5 Novartis AG Recent Development

11.10 Oncology Research International Ltd

11.10.1 Oncology Research International Ltd Company Details

11.10.2 Oncology Research International Ltd Business Overview

11.10.3 Oncology Research International Ltd Actinic (Solar) Keratosis Treatment Introduction

11.10.4 Oncology Research International Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.10.5 Oncology Research International Ltd Recent Development

11.11 Promius Pharma LLC

11.11.1 Promius Pharma LLC Company Details

11.11.2 Promius Pharma LLC Business Overview

11.11.3 Promius Pharma LLC Actinic (Solar) Keratosis Treatment Introduction

11.11.4 Promius Pharma LLC Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.11.5 Promius Pharma LLC Recent Development

11.12 Valeant Pharmaceuticals International Inc

11.12.1 Valeant Pharmaceuticals International Inc Company Details

11.12.2 Valeant Pharmaceuticals International Inc Business Overview

11.12.3 Valeant Pharmaceuticals International Inc Actinic (Solar) Keratosis Treatment Introduction

11.12.4 Valeant Pharmaceuticals International Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.12.5 Valeant Pharmaceuticals International Inc Recent Development

11.13 Vectura Group Plc

11.13.1 Vectura Group Plc Company Details

11.13.2 Vectura Group Plc Business Overview

11.13.3 Vectura Group Plc Actinic (Solar) Keratosis Treatment Introduction

11.13.4 Vectura Group Plc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025)

11.13.5 Vectura Group Plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

3M Drug Delivery Systems

Athenex Inc

CritiTech Inc

Foamix Pharmaceuticals Ltd

G&E Herbal Biotechnology Co Ltd

Galderma SA

Laboratories Ojer Pharma SL

LEO Pharma A/S

Novartis

Oncology Research International Ltd

Promius Pharma LLC

Valeant Pharmaceuticals International Inc

Vectura Group plc

List of Tables

Table 1. Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 854-A

Table 3. Key Players of ACT-01

Table 4. Key Players of AD-17137

Table 5. Key Players of Celecoxib

Table 6. Key Players of DFD-08

Table 7. Key Players of GDC-695

Table 8. Key Players of Others

Table 9. Global Actinic (Solar) Keratosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Actinic (Solar) Keratosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Actinic (Solar) Keratosis Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Actinic (Solar) Keratosis Treatment Market Share by Region (2020-2025)

Table 13. Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Actinic (Solar) Keratosis Treatment Market Share by Region (2026-2031)

Table 15. Actinic (Solar) Keratosis Treatment Market Trends

Table 16. Actinic (Solar) Keratosis Treatment Market Drivers

Table 17. Actinic (Solar) Keratosis Treatment Market Challenges

Table 18. Actinic (Solar) Keratosis Treatment Market Restraints

Table 19. Global Actinic (Solar) Keratosis Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Actinic (Solar) Keratosis Treatment Market Share by Players (2020-2025)

Table 21. Global Top Actinic (Solar) Keratosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Actinic (Solar) Keratosis Treatment as of 2024)

Table 22. Ranking of Global Top Actinic (Solar) Keratosis Treatment Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Actinic (Solar) Keratosis Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Actinic (Solar) Keratosis Treatment, Headquarters and Area Served

Table 25. Global Key Players of Actinic (Solar) Keratosis Treatment, Product and Application

Table 26. Global Key Players of Actinic (Solar) Keratosis Treatment, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Actinic (Solar) Keratosis Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2020-2025)

Table 30. Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2026-2031)

Table 32. Global Actinic (Solar) Keratosis Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Application (2020-2025)

Table 34. Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Application (2026-2031)

Table 36. North America Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 51. 3M Drug Delivery Systems Company Details

Table 52. 3M Drug Delivery Systems Business Overview

Table 53. 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Product

Table 54. 3M Drug Delivery Systems Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 55. 3M Drug Delivery Systems Recent Development

Table 56. Athenex Inc Company Details

Table 57. Athenex Inc Business Overview

Table 58. Athenex Inc Actinic (Solar) Keratosis Treatment Product

Table 59. Athenex Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 60. Athenex Inc Recent Development

Table 61. CritiTech Inc Company Details

Table 62. CritiTech Inc Business Overview

Table 63. CritiTech Inc Actinic (Solar) Keratosis Treatment Product

Table 64. CritiTech Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 65. CritiTech Inc Recent Development

Table 66. Foamix Pharmaceuticals Ltd Company Details

Table 67. Foamix Pharmaceuticals Ltd Business Overview

Table 68. Foamix Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Product

Table 69. Foamix Pharmaceuticals Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 70. Foamix Pharmaceuticals Ltd Recent Development

Table 71. G&E Herbal Biotechnology Co Ltd Company Details

Table 72. G&E Herbal Biotechnology Co Ltd Business Overview

Table 73. G&E Herbal Biotechnology Co Ltd Actinic (Solar) Keratosis Treatment Product

Table 74. G&E Herbal Biotechnology Co Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 75. G&E Herbal Biotechnology Co Ltd Recent Development

Table 76. Galderma SA Company Details

Table 77. Galderma SA Business Overview

Table 78. Galderma SA Actinic (Solar) Keratosis Treatment Product

Table 79. Galderma SA Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 80. Galderma SA Recent Development

Table 81. Laboratories Ojer Pharma SL Company Details

Table 82. Laboratories Ojer Pharma SL Business Overview

Table 83. Laboratories Ojer Pharma SL Actinic (Solar) Keratosis Treatment Product

Table 84. Laboratories Ojer Pharma SL Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 85. Laboratories Ojer Pharma SL Recent Development

Table 86. LEO Pharma A/S Company Details

Table 87. LEO Pharma A/S Business Overview

Table 88. LEO Pharma A/S Actinic (Solar) Keratosis Treatment Product

Table 89. LEO Pharma A/S Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 90. LEO Pharma A/S Recent Development

Table 91. Novartis AG Company Details

Table 92. Novartis AG Business Overview

Table 93. Novartis AG Actinic (Solar) Keratosis Treatment Product

Table 94. Novartis AG Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 95. Novartis AG Recent Development

Table 96. Oncology Research International Ltd Company Details

Table 97. Oncology Research International Ltd Business Overview

Table 98. Oncology Research International Ltd Actinic (Solar) Keratosis Treatment Product

Table 99. Oncology Research International Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 100. Oncology Research International Ltd Recent Development

Table 101. Promius Pharma LLC Company Details

Table 102. Promius Pharma LLC Business Overview

Table 103. Promius Pharma LLC Actinic (Solar) Keratosis Treatment Product

Table 104. Promius Pharma LLC Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 105. Promius Pharma LLC Recent Development

Table 106. Valeant Pharmaceuticals International Inc Company Details

Table 107. Valeant Pharmaceuticals International Inc Business Overview

Table 108. Valeant Pharmaceuticals International Inc Actinic (Solar) Keratosis Treatment Product

Table 109. Valeant Pharmaceuticals International Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 110. Valeant Pharmaceuticals International Inc Recent Development

Table 111. Vectura Group Plc Company Details

Table 112. Vectura Group Plc Business Overview

Table 113. Vectura Group Plc Actinic (Solar) Keratosis Treatment Product

Table 114. Vectura Group Plc Revenue in Actinic (Solar) Keratosis Treatment Business (2020-2025) & (US$ Million)

Table 115. Vectura Group Plc Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Actinic (Solar) Keratosis Treatment Picture

Figure 2. Global Actinic (Solar) Keratosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Actinic (Solar) Keratosis Treatment Market Share by Type: 2024 VS 2031

Figure 4. 854-A Features

Figure 5. ACT-01 Features

Figure 6. AD-17137 Features

Figure 7. Celecoxib Features

Figure 8. DFD-08 Features

Figure 9. GDC-695 Features

Figure 10. Others Features

Figure 11. Global Actinic (Solar) Keratosis Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Actinic (Solar) Keratosis Treatment Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Clinic Case Studies

Figure 15. Others Case Studies

Figure 16. Actinic (Solar) Keratosis Treatment Report Years Considered

Figure 17. Global Actinic (Solar) Keratosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Actinic (Solar) Keratosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Actinic (Solar) Keratosis Treatment Market Share by Region: 2024 VS 2031

Figure 20. Global Actinic (Solar) Keratosis Treatment Market Share by Players in 2024

Figure 21. Global Top Actinic (Solar) Keratosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Actinic (Solar) Keratosis Treatment as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Actinic (Solar) Keratosis Treatment Revenue in 2024

Figure 23. North America Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Actinic (Solar) Keratosis Treatment Market Share by Country (2020-2031)

Figure 25. United States Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Actinic (Solar) Keratosis Treatment Market Share by Country (2020-2031)

Figure 29. Germany Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Share by Region (2020-2031)

Figure 37. China Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Actinic (Solar) Keratosis Treatment Market Share by Country (2020-2031)

Figure 45. Mexico Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Share by Country (2020-2031)

Figure 49. Turkey Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. 3M Drug Delivery Systems Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 53. Athenex Inc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 54. CritiTech Inc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 55. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 56. G&E Herbal Biotechnology Co Ltd Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 57. Galderma SA Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 58. Laboratories Ojer Pharma SL Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 59. LEO Pharma A/S Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 60. Novartis AG Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 61. Oncology Research International Ltd Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 62. Promius Pharma LLC Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 63. Valeant Pharmaceuticals International Inc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 64. Vectura Group Plc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Actinic (Solar) Keratosis Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-7I3162

Global Actinic (Solar) Keratosis Treatment Market Research Report 2025

FEATURED COMPANIES

Actinic (Solar) Keratosis Treatment Market Size

Actinic (Solar) Keratosis Treatment Market

Scope of Actinic (Solar) Keratosis Treatment Market Report

Chapter Outline

FAQ for this report

How fast is Actinic (Solar) Keratosis Treatment Market growing?

What is the Actinic (Solar) Keratosis Treatment Market size in 2031?

Who are the main players in the Actinic (Solar) Keratosis Treatment Market report?

What are the Application segmentation covered in the Actinic (Solar) Keratosis Treatment Market report?

What are the Type segmentation covered in the Actinic (Solar) Keratosis Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS